The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated. The treatment, called Amtagvi, ...

A modified immunotherapy regimen for advanced melanoma showed a 49% response rate and extended median overall survival to 42 months. The modified regimen, with lower Yervoy and higher Opdivo doses, ...

This story is sponsored by Intermountain LiveWell. Utahns who have advanced melanoma cancer no longer have to leave the state to get a groundbreaking new treatment that is showing promise for patients ...

The FDA recently approved the first tumor-infiltrating lymphocyte, or TIL, therapy to treat advanced melanoma, and 27 institutions have so far been authorized to deliver the treatment. Federal ...

The FDA has approved a groundbreaking therapy for patients with late-stage melanoma. Melanoma is an aggressive skin cancer that's the fifth most deadly. Too much sun is the leading cause of skin ...

Less might be more when it comes to immunotherapy treatment of melanoma, a new study says. Lower doses of a drug used to ...

The Food and Drug Administration approved a groundbreaking cellular treatment Friday for two types of advanced melanoma aimed at combating tumor growth in adult patients with the skin cancer who have ...

IBI363, a bispecific antibody, targets PD-1 and enhances IL-2, improving T cell function in melanoma treatment. The FDA's fast track designation aims to expedite IBI363's development and approval for ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

CLEVELAND — We love the sun in Northeast Ohio, but we also need to respect it. Too much of it — too many sunburns, too much time unprotected — can be dangerous and potentially lead to skin cancer.

The News On 6 weekend team provides a comprehensive look at updated news events, a detailed and up-to-the-minute weather forecast, and the latest sports highlights. TULSA, Okla. - The FDA has approved ...